News Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:30:43 2025-06-16 am EDT			5-day change	1st Jan Change
262.90 ^CHF	-2.52%		-2.56%	+2.90%

01:56pm	Sarepta shares crash as second patient dies after receiving its gene therapy	RE
12:06pm	Swiss Stocks Kick Off New Trading Week Downbeat Amid Gloomy Economic Forecasts	MT

Sarepta shares crash as second patient dies after receiving its gene therapy	01:56pm	RE
Swiss Stocks Kick Off New Trading Week Downbeat Amid Gloomy Economic Forecasts	12:06pm	MT
Genentech Provides Update on Phase III Verona Study	11:31am	BU
Analyst recommendations: Meta, Eli Lilly, RTX Corp, Airbus, Roche…	10:44am
AbbVie says blood cancer drug fails late-stage trial	10:20am	RE
Upcoming Fed Meeting Eyed as US Equity Futures Rise Pre-Bell	09:04am	MT
North American Morning Briefing : Stock Futures Rise As Israel-Iran Conflict Enters Fourth Day	06:13am	DJ
Prothena's Partner to Advance Potential Parkinson's Treatment to Phase 3 Development	03:58am	MT
Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures	03:40am	DJ
Roche: moving towards phase 3 in Parkinson's disease	02:31am	CF
Roche to Advance Prasinezumab Into Phase 3 Trial for Early-Stage Parkinson's Disease	01:33am	DJ
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease	01:16am	BU
Roche to Proceed with Phase Three Development of Investigational Drug for Parkinson's Disease	01:11am	MT
Roche To Advance Prasinezumab Into Phase III Development For Early-Stage Parkinson's Disease	01:03am	RE
Swiss stocks - Factors to watch on June 16	12:56am	RE
Sarepta reports second case of liver failure death after its gene therapy treatment	Jun. 15	RE
Roche Updates Treatment Profile, Dosing Restrictions for Duchenne Muscular Dystrophy Treatment	Jun. 15	MT
Roche Provides Safety Update On Elevidys(TM) Gene Therapy For Duchenne Muscular Dystrophy In Non-Ambulatory Patients	Jun. 15	RE
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial	Jun. 13	RE
US FDA approves Nuvation Bio's rare lung cancer drug	Jun. 11	RE
Roche Canada Says Health Canada Authorizes PiaSky	Jun. 11	RE
EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio	Jun. 11	DJ
EQT leads financing round in SpliceBio	Jun. 11	FW
Pharma Mar's Supplemental New Drug Application for Lung Cancer Drug Combo Gets US FDA Priority Review	Jun. 10	MT
Roche's Middle Eastern Arm Launches Sustainable Healthcare Lab Certification Initiative	Jun. 10	MT